StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$237.85−0.34 (-0.14%)

Close on Nov 17, 2026Market cap $33.46BP/E 21.7Yield 1.01%

ResMed total assets

Total assets on the balance sheet at the end of each period.

ResMed's total assets was $8.21B at Sep 30, 2026. For fiscal 2026 it was $8.97B, up 9.7% from the year before. Over ten years it grew 10.7% a year on average. The highest annual figure on record is $8.97B in fiscal 2026.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$8.97B+9.7%
FY2025Jun 30, 2025$8.17B+18.9%
FY2024Jun 30, 2024$6.87B+1.8%
FY2023Jun 30, 2023$6.75B+32.5%
FY2022Jun 30, 2022$5.10B+7.8%
FY2021Jun 30, 2021$4.73B+3.1%
FY2020Jun 30, 2020$4.59B+11.7%
FY2019Jun 30, 2019$4.11B+34.1%
FY2018Jun 30, 2018$3.06B-11.7%
FY2017Jun 30, 2017$3.47B+6.5%
FY2016Jun 30, 2016$3.26B+49.3%
FY2015Jun 30, 2015$2.18B-7.6%
FY2014Jun 30, 2014$2.36B+6.8%
FY2013Jun 30, 2013$2.21B+3.4%
FY2012Jun 30, 2012$2.14B+3.3%
FY2011Jun 30, 2011$2.07B+27.2%
FY2010Jun 30, 2010$1.63B–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$8.21B-1.2%
Q4 FY2026CQ2 2026Jun 30, 2026$8.97B+9.7%
Q3 FY2026CQ1 2026Mar 31, 2026$8.78B+16.1%
Q2 FY2026CQ4 2025Dec 31, 2025$8.50B+19.1%
Q1 FY2026CQ3 2025Sep 30, 2025$8.31B+15.0%
Q4 FY2025CQ2 2025Jun 30, 2025$8.17B+18.9%
Q3 FY2025CQ1 2025Mar 31, 2025$7.57B+11.0%
Q2 FY2025CQ4 2024Dec 31, 2024$7.14B+3.4%
Q1 FY2025CQ3 2024Sep 30, 2024$7.22B+7.1%
Q4 FY2024CQ2 2024Jun 30, 2024$6.87B+1.8%
Q3 FY2024CQ1 2024Mar 31, 2024$6.81B+1.5%
Q2 FY2024CQ4 2023Dec 31, 2023$6.91B+3.4%
Q1 FY2024CQ3 2023Sep 30, 2023$6.74B+30.2%
Q4 FY2023CQ2 2023Jun 30, 2023$6.75B+32.5%
Q3 FY2023CQ1 2023Mar 31, 2023$6.71B+36.9%
Q2 FY2023CQ4 2022Dec 31, 2022$6.68B+41.0%
Q1 FY2023CQ3 2022Sep 30, 2022$5.18B+9.5%
Q4 FY2022CQ2 2022Jun 30, 2022$5.10B+7.8%
Q3 FY2022CQ1 2022Mar 31, 2022$4.91B+7.0%
Q2 FY2022CQ4 2021Dec 31, 2021$4.73B+3.5%
Q1 FY2022CQ3 2021Sep 30, 2021$4.73B+2.3%
Q4 FY2021CQ2 2021Jun 30, 2021$4.73B+3.1%
Q3 FY2021CQ1 2021Mar 31, 2021$4.59B+1.7%
Q2 FY2021CQ4 2020Dec 31, 2020$4.57B+5.0%
Q1 FY2021CQ3 2020Sep 30, 2020$4.62B+11.2%
Q4 FY2020CQ2 2020Jun 30, 2020$4.59B+11.7%
Q3 FY2020CQ1 2020Mar 31, 2020$4.51B+10.1%
Q2 FY2020CQ4 2019Dec 31, 2019$4.35B+12.8%
Q1 FY2020CQ3 2019Sep 30, 2019$4.15B+35.4%
Q4 FY2019CQ2 2019Jun 30, 2019$4.11B+34.1%
Q3 FY2019CQ1 2019Mar 31, 2019$4.10B+16.0%
Q2 FY2019CQ4 2018Dec 31, 2018$3.86B+8.3%
Q1 FY2019CQ3 2018Sep 30, 2018$3.07B-12.1%
Q4 FY2018CQ2 2018Jun 30, 2018$3.06B-11.7%
Q3 FY2018CQ1 2018Mar 31, 2018$3.53B+3.3%
Q2 FY2018CQ4 2017Dec 31, 2017$3.56B+7.3%
Q1 FY2018CQ3 2017Sep 30, 2017$3.49B–
Q4 FY2017CQ2 2017Jun 30, 2017$3.47B–
Q3 FY2017CQ1 2017Mar 31, 2017$3.42B–
Q2 FY2017CQ4 2016Dec 31, 2016$3.32B–

More ResMed figures

See a number that looks wrong?